CLINICAL_TRIALS
trial_result
· 2013-11-25
Clinical Trial Update: Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease [Phase 3]
Summary
Phase 3 clinical trial update evaluating safety and efficacy of new eye drop formulations with Refresh Tears for dry eye disease completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Dry Eye Syndromes | Phase 3 | Status: COMPLETED | Results posted: 2013-11-25